Cara Therapeutics
Why Robinhood?
You can watch CARA and buy or sell other stocks, ETFs, and their options commission-free!About CARA
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
CARA Key Statistics
Stock Snapshot
With a market cap of 149.73M, Cara Therapeutics(CARA) trades at $15.96. The stock has a price-to-earnings ratio of -0.51.
On 2026-04-08, Cara Therapeutics(CARA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Cara Therapeutics(CARA) stock has reached 0, versus its average volume of 65.3K.
The stock's 52-week range extends from a low of $2.75 to a high of $43.65.
The stock's 52-week range extends from a low of $2.75 to a high of $43.65.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.